The development of new triazole based inhibitors of tumor necrosis factor-α (TNF-α) production
- 19 May 2003
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (10) , 1665-1668
- https://doi.org/10.1016/s0960-894x(03)00238-5
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Chapter 18. Inhibitors of p38α MAP kinasePublished by Elsevier ,2002
- Targeting Tumour Necrosis Factor in the Treatment of Rheumatoid ArthritisBioDrugs, 2001
- 1 p38 MAP Kinase: Molecular Target for the Inhibition of Pro-inflammatory CytokinesPublished by Elsevier ,2001
- New aryl/heteroaryl CN bond cross-coupling reactions via arylboronic acid/cupric acetate arylationTetrahedron Letters, 1998
- The Future Role of Anti-Tumour Necrosis Factor (TNF) Products in the Treatment of Rheumatoid ArthritisDrugs, 1998
- Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion ProteinNew England Journal of Medicine, 1997
- Cytokines in autoimmunityCurrent Opinion in Immunology, 1996
- Ethenylation and Alkynylation in Palladium-Catalyzed Carbosubstitution in Heteroazines.Acta Chemica Scandinavica, 1996
- 2,4,5- triarylimidazole inhibitors of IL-1 biosynthesisBioorganic & Medicinal Chemistry Letters, 1995
- Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processingNature, 1994